RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas

European Archives of Oto-Rhino-Laryngology

Volumn 262, Issue 5, 2005, Pages 368-373

  Nibu, Ken Ichi ^a   Otsuki, Naoki ^a   Nakao, Kazunari ^b   Sugasawa, Masashi ^b   Rothstein, Jay L ^c  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Fusion gene; Japanese; ret PTC; Thyroid carcinoma

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; FOLLICULAR CARCINOMA; FUSION GENE; GENE ACTIVATION; GENE FUNCTION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JAPAN; MEDULLARY CARCINOMA; ONCOGENE RET; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CARCINOMA; TUMOR DIFFERENTIATION;

ADENOMA; ADOLESCENT; ADULT; CARCINOMA, PAPILLARY; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE FUSION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS;

EID: 20044368066     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-004-0835-8     Document Type: Article

References (13)

1. Cheung CC, Carydis B, Ezzat S, Bedard YC, Asa SL (2001) Analysis of ret/PTC gene rearrangements refines the fine-needle aspiration diagnosis of thyroid cancer. J Clin Endocrinol Metab 86:2187-2190
2. Klugbauer S, Lengfelder E, Demidchik EP, Rabes HM (1995) High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 11:2459-2467
3. Mai KT, Vaccani JP, Thomas J, Odell PF (2001) Immunostaining for ret oncogene proteins in papillary thyroid carcinoma: a correlation of ret immunoreactivity and potential of lymph node metastasis. Thyroid 11:859-863
4. Motomura T, Nikiforov YE, Namba H, Ashizawa K, Nagataki S, Yamashita S, Fagin JA (1998) ret rearrangements in Japanese pediatric and adult papillary thyroid cancers. Thyroid 8:485-489
5. Nikiforov YE, Nikiforova MN, Gnepp DR, Fagin JA (1996) Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after Chernobyl nuclear. Oncogene 13:687-697
6. Powell D, Russell J, Nibu K, Li K, Rhee E, Liao M, Goldstein M, Keane WM, Santoro M, Fusco A, Rothstein JL (1998) The RET/PTC3 oncogene: metastatic solid-type carcinomas in murine thyroids. Cancer Res 58:5523-5528
7. Santoro M, Papotti M, Chiappetta G, Garcia-Rostan G, Volante M, Johnson C, Camp RL, Pentimalli F, Monaco C, Herrero A, Carcangiu ML, Fusco A, Tallini G (2002) RET activation and clinicopathologic features in poorly differentiated thyroid tumors. J Clin Endocrinol Metab 87:370-379
8. Takahashi M (1995) Oncogenic activation of the ret portooncogene in thyroid cancer. Crit Rev Oncog 6:35-46
9. Takahashi M (2001) The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev 12:361-373
10. Tallini G, Asa L (2001) RET oncogene activation in papillary thyroid carcinoma. Adv Anat Pathol 8:345-354
11. Tallini G, Santoro M, Helie M, Carlomagno F, Salvatore G, Chiappetta G, Carcangiu ML, Fusco A (1998) RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidince of progression to poorly differentiated or undifferentiated tumor phenotypes. Clinical Cancer Res 4:287-294
12. Wajjwalku W, Nakamura S, Hasegawa Y, Miyazaki K, Satoh Y, Funahashi H, Matsuyama M, Takahashi M (1992) Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Jpn J Cancer Res 83:671-675
13. Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, Multhaupt H, Atkins JP, Rosen MR, Keane W, Rothstein JL (1997) Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope 107:95-100